June 17, 2025 a 03:43 pm
ISRG: Fundamental Ratio Analysis - Intuitive Surgical, Inc.
Intuitive Surgical, Inc. is a strong player in the medical instruments market, known for its innovative surgical systems. Despite recent market fluctuations, the company's ability to enhance minimally invasive care globally makes its stock an interesting consideration for investors. With stable growth and promising technology advancements, the stock presents both opportunities and risks.
Fundamental Rating
Intuitive Surgical holds a 'B-' fundamental rating, indicating solid financial health with room for improvement in certain areas.
| Category | Score | Visualization |
|---|---|---|
| Discounted Cash Flow | 3 | |
| Return on Equity | 4 | |
| Return on Assets | 5 | |
| Debt to Equity | 1 | |
| Price to Earnings | 1 | |
| Price to Book | 1 |
Historical Rating
The current and previous fundamental scores illustrate the consistent performance of Intuitive Surgical.
| Date | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2025-06-16 | 3 | 3 | 4 | 5 | 1 | 1 | 1 |
| n/a | 0 | 3 | 4 | 5 | 1 | 1 | 1 |
Analyst Price Targets
Analysts show a positive outlook with high, median, and low targets supporting potential growth.
| High | Low | Median | Consensus |
|---|---|---|---|
| $605 | $560 | $600 | $588.33 |
Analyst Sentiment
Analyst sentiment remains optimistic with a consensus classification of 'Buy'.
| Recommendation | Number | Distribution |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 37 | |
| Hold | 10 | |
| Sell | 5 | |
| Strong Sell | 0 |
Conclusion
Intuitive Surgical, Inc. provides a compelling investment case with robust technology offerings and stable market performance. The stock's fundamental ratings highlight certain financial areas requiring improvement, but overall, the company maintains a strong position in the market. Analyst consensus indicates confidence in future growth, although potential investors should weigh the historical performance and current market conditions. Opportunities in expanding minimally invasive care are a significant advantage, but financial metrics caution diligence.